Product Images Risedronate Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Risedronate Sodium NDC 0115-1426 by Impax Generics, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - risedronate sodium delayed release tablets 1
Figure 1 - risedronate sodium delayed release tablets 2
This is a graph (Figure 1) showing the percentage of patients who developed nonvertebral fractures related to osteoporosis over a period of 3 years. The graph includes data from two studies: VERT MN and VERT NA. There are six different types of fractures shown (wrist, humerus, hip, pelvis, leg, and clavicle) and two treatment options (placebo and ACTONEL 5mg).*
carton - risedronate sodium delayed release tablets 3
This is a medication guide for Risedronate Sodium Delayed-Release Tablets, with a strength of 35 mg, to be taken once a week on the same day every week. The tablets must be swallowed whole immediately after breakfast with at least 2 ounces of plain water. The patient should not lie down for at least 30 minutes, chew, cut or crush the tablet. Calcium supplements, antacids, magnesium-based supplements, laxatives, and iron preparations should not be taken at the same time of the day. The NDC code is 0115142634.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.